AzTrials
AzTrials

InfertilityNCT02329704

Evaluation Study Between Density Gradient and Swimming Down for Semen Processing

An observational study of Infertility, run by Ahmad Mustafa Mohamed Metwalley at 2 sites in 2 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study evaluates the quality of sperm produced after semen processing using Density Gradient (DG) and swimming down (SD). Read more about this study

Who is it for?
Ages 18 to 60 years, men only
Conditions the study is for
Infertility
What is being tested?
Diff-Quik staining for morphology evaluation, Motility Evaluation for grade A and B and Concentration (mil/ml)
Type of treatment
Surgery or procedure
How many people
100 participants
Where
2 sitesin 2 countries
Study dates
May 2007to Sep 2007
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • Men only
  • No healthy volunteers
  • Adult

Study population: Cases arranged for study were submitted for routine semen analysis. Patient agreements collected as consent form signed during sample submission.

Who may be able to join

  • Semen with motility more than 10 % according WHO 2010 standers
  • Semen with sperm count more than 5 mil/ml according WHO 2010 standers

Who cannot join

  • Semen volume less than 1.0 ml
  • Semen with liquefaction time more than 60 min

Trial locations and contacts

2 sites in 2 countries.

2 sites in 2 countries

Bahrain1 site
  • Al Baraka Fertility Hospital

    Manama, Adliyah, 15006

Other trials in Bahrain

Egypt1 site
  • Ibn Sina IVF Center- Ibn Sina Hospital

    Sohag, Sohag Governorate, 15006

Other trials in Egypt

About this study

This study evaluates the quality of sperm produced after semen processing using Density Gradient (DG) and swimming down (SD).

Read the detailed description

Semen processing to be used for different ART procedures is essential step to isolate dead sperms as well as those abnormally structural or morphology. Semen preparation will maintain to remove the seminal fluids and present cells and contamination pus cells or bacterial cells.

Among different protocols, Density Gradient and swim-up are the most common. For poor motility and number sample Density Gradient is indicated. While final evaluation for produced or separated sperm form processing procedures was not evaluated yet.

Preparation for evaluation study to compare output of main used protocol Density Gradient (DG) with other protocol as swimming down using different study criteria can make more clear evaluation for better processing procedures.

The cases arranged for evaluation were semen samples are within WHO 2010 normal values for motility and count to be more than 5 million/ml. All samples to be divided to two portions for processing by the two preparation techniques.

Post preparation evaluation to be done for the two outputs using: Motility monitoring for 48 hours at 37.0 Dc, abnormal forms, hyaluronan affinity testing and contaminating bacterial growth.

In this study we will show drawback effect of physical and time stress interface applied on sperms during processing, and compare the out put results with that results produced from sperm processed without centrifugation interface or more processing time. As the sperm will separate it self by its natural movement and normal behavior.

Evaluation will be on three categories:

  1. The final output quality: as net highly progressive sperms and their count number ( sperm morphology, count and motility): as our results showed more phonologically normal sperm retrieved from SD method with higher count and more percentage of progressively motile sperms.
  2. The quality of sperm produced: through monitoring sperm vitality testing or sperm motility power among 2 days at 37.0 Ds. Motility will be evaluated after 24 hours and 48 hours. Both readings showed more decrease in sperm motility and vitality with time consuming with portions processed using density gradient. While portions processed using SD showed significant better readings. Another functional activity of sperm post processing is using HBA testing slide, as we evaluate the sperm affinity to hyaluronan. This Testing or assay indicate the physiological activity of sperm still maintained. While it showed HBA higher significant results with swimming down group study.
  3. Final evaluation, that are used to present the quality of separation: is monitored using the contamination and carry over effect during semen manipulation and processing. Bacterial contamination using routine culture media (Blood agar) to evaluate 5 microns from each portions for presence and absence of any bacterial cells or during processing and manipulation.
Conditions
Infertility
Being tested
Diff-Quik staining for morphology evaluation, Motility Evaluation for grade A and B, Concentration (mil/ml), 24 H half life, 48 H half life
Keywords
IUI/AIH, Semen preparation, Semen processing, ICSI/IVF, ART, Density Gradient, Swimming down, hyaluronan affinity testing, Sperm vitality testin
Medical subject headings
Infertility

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Diff-Quik staining for morphology evaluationProcedure or surgery

    Also called Abnormal forms %

    Papanicolaou stain (haematoxylin, orange G6, and EA50) gives a clear difference between basophilic and acidophilic cell constituents and thereby enables a detailed examination of chromatin pattern, which is useful in the evaluation of sperm morphology and assessment of presence of immature spermatozoa. Cytoplasmic staining can vary between red and green dependent on ionic strength, pH, and composition of the cell department and the stain (OG6 and EA50).

    Morphological assessment for processed portions of semen. As separation process has to minimize the morphological abnormal sperm.

  • Motility Evaluation for grade A and BProcedure or surgery

    Also called Motility %

    The better separation method will insure more progressive sperms after processing.

    Grading using A and B scale scored by (WHO 2010) references.

  • Concentration (mil/ml)Procedure or surgery

    Also called Concentration for final output

    count of isolated sperms Using Makler chamber for count of sperm for each portion post processing.

  • 24 H half lifeProcedure or surgery

    Also called Motility after 24 hours incubation at 37 Dc.

    percentage of active motile to non motile sperms.

    Microscopic examination for each sample after 24 hours incubation, to evaluate the progressively motile sperm and those non progressive or non motile.

  • 48 H half lifeProcedure or surgery

    Also called Motility evaluation after 48hours incubation at 37 Dc.

    percentage of active motile to non motile sperms.

    Microscopic examination for each sample after 48 hours incubation, to evaluate the progressively motile sperm and those non progressive or non motile.

  • HBA TestingProcedure or surgery

    Also called Sperm physioogical activity evaluation HA binding

    The Hyaluronic Binding Assay (HBA®) is an important diagnostic tool for suspected male infertility in the analysis of semen. In a matter of minutes the HBA® slide provides an answer to the proportion of mature binding spermatozoa in the sample (The HBA® score %).

    By using HBA slide we can count the physiologically active sperms at each sample and calculate percentage of active sperms with reference to post processing count from 3rd investigating arm.

  • Bacterial contaminationBiological

    Also called Bacterial contamination presence of post processinf samples

    Routine bacterial culture using Blood Agar culture plates for 10 micron finally washed samples, to confirm presence of any bacteria contamination caused by carry over during processing.

Study groups in NCT02329704
Study groupRoleWhat they receive
Density Gradient processingSemen portion processed using Density Gradient (80/40 %) Spin on 1200 r.p.m./20min Wash on 1200 r.p.m./5min Rewash on 1200 r.p.m./5min then evaluation to be done using : Diff-Quik staining for morphology evaluation Motility Evaluation for grade A and B Concentration (mil/ml) 24 H half life 48 H half life HBA Testing Bacterial contamination
Receives: Procedure: Diff-Quik staining for morphology evaluation; Procedure: Motility Evaluation for grade A and B; Procedure: Concentration (mil/ml); Procedure: 24 H half life; Procedure: 48 H half life; Procedure: HBA Testing; Biological: Bacterial contamination
Swimming down ProcessingSemen portion processed using swimming down (100 %) 30 min at room temperature processing for swim down Wash on 1200 r.p.m./5min Rewash on 1200 r.p.m./5min then evaluation to be done using : Diff-Quik staining for morphology evaluation Motility Evaluation for grade A and B Concentration (mil/ml) 24 H half life 48 H half life HBA Testing Bacterial contamination
Receives: Procedure: Diff-Quik staining for morphology evaluation; Procedure: Motility Evaluation for grade A and B; Procedure: Concentration (mil/ml); Procedure: 24 H half life; Procedure: 48 H half life; Procedure: HBA Testing; Biological: Bacterial contamination

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. HBA

    Affinity is measured according to percentage of non motile sperm produced from 10 µL of processed sample.

    Measured: 1 day

  2. Abnormal forms

    Percentage normally stained sperms after processing

    Measured: 1 day

Secondary outcomes (3)
  1. Final concentration

    Concentration was fluctuation according to original motility and concentration, DG

    Measured: 1 day

  2. 24 Hour motility

    Motility evaluation after 37.0 Dc incubation

    Measured: 1 day

  3. 48 Hour motility

    Motility evaluation after 37.0 Dc incubation

    Measured: 2 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jan 2015 (estimated)
  2. Study startMay 2007
  3. Primary completionSep 2007
  4. Study completionSep 2007

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02329704
Sponsor's protocol ID
AlBarakaSD2
Status last verified
Dec 2014
First submitted
28 Dec 2014
Last updated
1 Jan 2015
Results posted
No
Data monitoring committee
No

Publications

  • Malvezzi H, Sharma R, Agarwal A, Abuzenadah AM, Abu-Elmagd M. Sperm quality after density gradient centrifugation with three commercially available media: a controlled trial. Reprod Biol Endocrinol. 2014 Dec 2;12:121. doi: 10.1186/1477-7827-12-121.

    PubMed 25466430

Questions about this trial

What is this clinical trial studying?

An observational study of Infertility, run by Ahmad Mustafa Mohamed Metwalley at 2 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Jan 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Bahrain, Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

HBA (time frame: 1 day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02329704, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Jan 2015.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in